^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    iNeo-Vac-R01

    i
    Other names: iNeo-Vac-R01
    Associations

    News

    Trials
    Company:
    Hangzhou Neoantigen Therap
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Recruiting, Sir Run Run Shaw Hospital | Not yet recruiting --> Recruiting
    Enrollment open • Combination therapy
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Recruiting, Sir Run Run Shaw Hospital | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Recruiting, Sir Run Run Shaw Hospital | Not yet recruiting --> Recruiting
    Enrollment open • Combination therapy • Metastases
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Not yet recruiting, Sir Run Run Shaw Hospital
    New P1 trial • Combination therapy
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Not yet recruiting, Sir Run Run Shaw Hospital
    New P1 trial • Combination therapy • Metastases
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01
    1year
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=20, Not yet recruiting, Sir Run Run Shaw Hospital
    New P1 trial • Metastases
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    iNeo-Vac-R01